UAMS Arkansas BioVentures and its Technology Licensing Office (TLO) were established as a formal outgrowth of the University of Arkansas for Medical Sciences’ (UAMS) interest in translating its research into products that benefit human health. The UAMS College of Medicine established UAMS BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the creation of startup companies that are based on UAMS technology invention disclosure, and contributions to Arkansas' economic development. UAMS BioVentures links the research minds at UAMS to global markets in order to advance Arkansas' scientific and economic development.
Primary Missions:
TLO – translate UAMS’ publicly funded research into products that benefit human healthcare by
- Supporting the faculty investigators in identifying, disclosing, patenting and licensing their inventions, as well as participation in Arkansas startup companies, and
- Developing strong Arkansas Research Alliances with other research institutions, specifically, the University of Arkansas System, Arkansas State University, the FDA's National Center for Toxicology Research, and the USDA's Aquaculture Station Stuttgart and the medical and biotechnology companies in the Mid-south Region, and
- Creating an infrastructure to support both technology transfer and startup company development.
UAMS BioVentures – convert Arkansas’ medical and biotechnology research into new companies and high wage jobs for Arkansans by
- Operating UAMS’ startup company incubator program under the guidance of the UAMS Arkansas BioVentures Advisory Board, and
- Developing an interactive network between UAMS, Arkansas Children’s Hospital, the Central Arkansas Veterans Healthcare System and global industries, and
- Supporting a state-of-the-art education and training programs that promote Arkansas’ medical and biotechnology development.
